| Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan) (NCT01230177) | Pfizer | 2011-05-01 |
| Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis (NCT01262118) | Pfizer | 2011-05-01 |
| A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. (NCT01302054) | Pfizer | 2011-05-01 |
| A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis (NCT01298531) | Pfizer | 2011-05-01 |
| Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan) (NCT01414257) | Pfizer | 2011-05-01 |
| Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679 (NCT01393652) | Pfizer | 2011-05-01 |
| A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine (NCT01302067) | Pfizer | 2011-05-01 |
| A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy (NCT01232556) | Pfizer | 2011-04-04 |
| Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®) (NCT01311505) | Pfizer | 2011-04-01 |
| Pediatric Pharmacokinetics And Safety Study Of Moxidectin (NCT01035619) | Pfizer | 2011-04-01 |
| A Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804 (NCT01313793) | Pfizer | 2011-04-01 |
| Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men. (NCT01293487) | Pfizer | 2011-04-01 |
| Scopolamine Challenge Study (NCT01213355) | Pfizer | 2011-04-01 |
| Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2. (NCT01339962) | Pfizer | 2011-04-01 |
| Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer (NCT01239745) | Pfizer | 2011-04-01 |
| Smoking Cessation Study In Healthy Adolescent Smokers (NCT01312909) | Pfizer | 2011-04-01 |
| Effects Of PF-02545920 On Ketamine-Induced Abnormal Prefrontal Brain Response To Associative Learning In Healthy Subjects (NCT01244880) | Pfizer | 2011-04-01 |
| A Study Of Gastrointestinal Tolerability Of PF05212389 In Obese Subjects (NCT01472848) | Pfizer | 2011-04-01 |
| A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma (NCT01320085) | Pfizer | 2011-03-24 |
| Studying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK) (NCT01121588) | Pfizer | 2011-03-22 |
| A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years. (NCT01323270) | Pfizer | 2011-03-18 |
| A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years (NCT01299480) | Pfizer | 2011-03-03 |
| A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers (NCT01314898) | Pfizer | 2011-03-01 |
| Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma (NCT01180049) | Pfizer | 2011-03-01 |
| Study To Investigate The Potential Drug Drug Interaction (DDI) Between PF-00299804 And Paroxetine In Healthy Subjects (NCT01318031) | Pfizer | 2011-03-01 |
| Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients (NCT01284062) | Pfizer | 2011-03-01 |
| Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females (NCT01301456) | Pfizer | 2011-03-01 |
| A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis (NCT01276639) | Pfizer | 2011-03-01 |
| Evaluate Parasitological Clearance Rates And Pharmacokinetics Of The Combination Of Azithromycin And Chloroquine In Asymptomatic Pregnant Women With Falciparum Parasitemia In Africa (NCT01103713) | Pfizer | 2011-03-01 |
| A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis (NCT01309737) | Pfizer | 2011-03-01 |
| Relative Bioavailability Of A Crizotinib Oral Liquid Formulation To Crizotinib Formulated Capsule (NCT01297595) | Pfizer | 2011-03-01 |
| CP-690-550 Ointment For Chronic Plaque Psoriasis (NCT01246583) | Pfizer | 2011-02-16 |
| Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China (NCT01176916) | Pfizer | 2011-02-09 |
| A Study To Compare The Amount Of CP-690,550 That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Two Different Strength Tablets Of CP-690,550 (NCT01277991) | Pfizer | 2011-02-01 |
| Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease (NCT01227564) | Pfizer | 2011-02-01 |
| A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022 (NCT01254656) | Pfizer | 2011-02-01 |
| Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance (NCT01210404) | Pfizer | 2011-02-01 |
| Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 Diabetes (NCT01285518) | Pfizer | 2011-02-01 |
| Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes (NCT01272804) | Pfizer | 2011-02-01 |
| Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes (NCT01258738) | Pfizer | 2011-02-01 |
| A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge (NCT01299467) | Pfizer | 2011-02-01 |
| Abuse Potential of Orally Administered Crushed Embeda Compared to Crushed Controlled-Release Morphine and Placebo in Non-Dependent Recreational Opioid Users (NCT01380093) | Pfizer | 2011-02-01 |
| A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy (NCT01287897) | Pfizer | 2011-02-01 |
| Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail (NCT01302119) | Pfizer | 2011-02-01 |
| Caverject User Study (NCT01008605) | Pfizer | 2011-02-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of NXL104 Alone and in Combination With Ceftazidime Administered as Single and Repeated Intravenous Doses in Healthy Japanese Subjects (NCT01291602) | Pfizer | 2011-02-01 |
| A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients (NCT01298518) | Pfizer | 2011-02-01 |
| Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder (NCT01260311) | Pfizer | 2011-02-01 |
| A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers (NCT01290900) | Pfizer | 2011-02-01 |
| Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia (NCT01243151) | Pfizer | 2011-02-01 |
| Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom (NCT01202253) | Pfizer | 2011-02-01 |
| A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis (NCT01240915) | Pfizer | 2011-02-01 |
| AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis (NCT01300052) | Pfizer | 2011-01-26 |
| Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes (NCT01226797) | Pfizer | 2011-01-17 |
| A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung (NCT01154140) | Pfizer | 2011-01-13 |
| Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors (NCT01286987) | Pfizer | 2011-01-03 |
| Study To Evaluate The Effect Of Single Intravenous Doses Of Tigecycline On QTc Intervals In Healthy Subjects (NCT01287793) | Pfizer | 2011-01-01 |
| Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema (NCT01189461) | Pfizer | 2011-01-01 |
| A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department (NCT01411215) | Pfizer | 2011-01-01 |
| This Study Is To Estimate The Time Course Of Pf-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers (NCT01272375) | Pfizer | 2011-01-01 |
| Drug Interaction Between Ritonavir And Sitaxsentan (NCT01251848) | Pfizer | 2011-01-01 |
| Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia (NCT01602874) | Pfizer | 2011-01-01 |
| Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers (NCT01314885) | Pfizer | 2011-01-01 |
| INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus (NCT01367457) | Pfizer | 2011-01-01 |
| Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year. (NCT01564771) | Pfizer | 2011-01-01 |
| A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma (NCT01225510) | Pfizer | 2011-01-01 |
| A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption (NCT01366287) | Pfizer | 2011-01-01 |
| Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma (NCT01210495) | Pfizer | 2010-12-06 |
| Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex) (NCT01229436) | Pfizer | 2010-12-01 |
| Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke (NCT01208233) | Pfizer | 2010-12-01 |
| Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease (NCT01238991) | Pfizer | 2010-12-01 |
| An Observational, Retrospective, Multicenter, National Study for the Monitoring of Subjects Who Participated in the LoadET Clinical Trial (NCT01793285) | Pfizer | 2010-12-01 |
| A Comparison Of The Pharmacokinetics Of PF-04191834 Following Single Dose Administration Of A Dispersion Formulation And A Suspension Formulation In Healthy Volunteers (NCT01265732) | Pfizer | 2010-12-01 |
| Bosutinib For Autosomal Dominant Polycystic Kidney Disease (NCT01233869) | Pfizer | 2010-12-01 |
| Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan (NCT01251835) | Pfizer | 2010-12-01 |
| Non-Interventional Study To Investigate Whether Information Provided To Patients Influences Their Satisfaction With Toviaz Therapy (NCT01091519) | Pfizer | 2010-12-01 |
| Study To Evaluate Pharmacokinetics Of Sirolimus In Stable Renal Transplant Recipients (NCT01236378) | Pfizer | 2010-12-01 |
| A Single Dose Escalation Study In Healthy Volunteers To Determine The Pharmacokinetics, Safety And Tolerability Of PF-05089771 In Healthy Volunteers (NCT01259882) | Pfizer | 2010-12-01 |
| Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain (NCT01428583) | Pfizer | 2010-12-01 |
| Acute Cough Study In Children (NCT01257542) | Pfizer | 2010-12-01 |
| Bosutinib In Subjects With Renal Impairment (NCT01233882) | Pfizer | 2010-12-01 |
| A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy (NCT01200394) | Pfizer | 2010-12-01 |
| A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis (NCT01176058) | Pfizer | 2010-12-01 |
| Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail (NCT01270971) | Pfizer | 2010-12-01 |
| A Multi-National Study To Assess How Effective And Safe The Smoking Cessation Medicine Varenicline Is In Smokers Who Have Already Tried Varenicline In The Past As A Prescription Medicine From Their Usual Healthcare Provider (NCT01244061) | Pfizer | 2010-12-01 |
| A Study Of Tasocitinib In Dry Eye Subjects (NCT01226680) | Pfizer | 2010-12-01 |
| A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066 (NCT01250730) | Pfizer | 2010-12-01 |
| This Is A Study Of Bioavailability And Food Effect For Fesoterodine. (NCT01286454) | Pfizer | 2010-12-01 |
| This Study Will Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers (NCT01258751) | Pfizer | 2010-12-01 |
| Single Dose Escalation Study of PF-05190457 in Healthy Volunteers (NCT01247896) | Pfizer | 2010-12-01 |
| Safety Study of Ointment for the Treatment of Plaque-type Psoriasis (NCT01258088) | Pfizer | 2010-11-30 |
| Multiple Dose Dental Pain Study Of Ibuprofen Extended Release (NCT01266161) | Pfizer | 2010-11-22 |
| Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis (NCT01100034) | Pfizer | 2010-11-19 |
| A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants. (NCT01250756) | Pfizer | 2010-11-01 |
| Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy (NCT01521884) | Pfizer | 2010-11-01 |
| A Study Comparing Drug Availability Of Methylprednisolone In Liquid Form Versus Methylprednisolone In Tablet Form (NCT01267201) | Pfizer | 2010-11-01 |
| A Study To Look At Safety And Blood Concentrations After Multiple Doses Of PF-03382792 In Healthy Elderly Individuals (NCT01089738) | Pfizer | 2010-11-01 |
| Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients (NCT01210443) | Pfizer | 2010-11-01 |
| Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE) (NCT01270711) | Pfizer | 2010-11-01 |
| A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis (NCT01241591) | Pfizer | 2010-11-01 |